2 very exciting small cap ASX shares to buy

ELMO Software Ltd (ASX:ELO) and this ASX small cap share could be worth watching closely. Here's why they have been given buy ratings…

| More on:
A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are a lot of options at the small end of the market for investors to choose from.

Two small caps that could be worth getting better acquainted with are listed below. Here's what you need to know about them:

ELMO Software Ltd (ASX: ELO)

ELMO is a cloud-based human resources and payroll software platform company. The company's increasingly popular platform streamlines a number of processes such as employee administration, recruitment, on-boarding, learning, performance, remuneration, compliance training, and payroll.

It recently released its half year results and revealed further strong growth in its annualised recurring revenue (ARR). At the end of December, ELMO's ARR reached a record $74.2 million. This was an increase of 42.8%. Management advised that this was underpinned by a combination of organic growth and the benefits of acquisitions.

Pleasingly, it still has a long runway for growth in the ANZ and UK markets. Furthermore, thanks to its jurisdiction agnostic platform, it has the option to expand internationally in the future.

Morgan Stanley is positive on the company. It currently has an overweight rating and $9.70 price target on its shares.

Mach7 Technologies Ltd (ASX: M7T)

Another small cap to look at is Mach7. It is a medical imaging data management solutions provider which uses software to create a clear and complete view of the patient.

In addition, management notes that Mach7's award-winning enterprise imaging platform provides a vendor neutral foundation for unstructured data consolidation and communication to power interoperability. This enables healthcare enterprises to build their best-of-breed clinical ecosystems.

Last month the company released its half year results and revealed that its ARR had grown to $10.2 million at the end of the period. This was up 88% on the prior corresponding period and provides 64% coverage of its operating expenses.

Analysts at Morgans appeared to be happy with its performance. In response, they retained their add rating and lifted their price target to $1.68.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Elmo Software and MACH7 FPO. The Motley Fool Australia has recommended Elmo Software and MACH7 FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Speculative

Speculative

Bell Potter says this speculative ASX stock can rocket 40%

If you have a high tolerance for risk, then it could be worth checking out Vitrafy Life Sciences Ltd (ASX:…

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Speculative

Why this speculative ASX stock could rise ~50%

Bell Potter sees potential for big returns over the next 12 months.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Speculative

These speculative ASX mining stocks could rise 85%+

Bell Potter has put speculative buy ratings on these stocks this morning.

Read more »

surprised asx investor appearing incredulous at hearing asx share price
Speculative

'Blockbuster opportunity': This speculative ASX stock could rise 70%

Bell Potter thinks exciting times could be around the corner for this buy-rated high risk stock.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Healthcare Shares

Buy this small cap ASX stock with a 'lucrative opportunity'

Bell Potter thinks this speculative stock could have major upside thanks to its US market opportunity.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Speculative

Broker says this speculative ASX stock could rise over 200%

This high risk option could have major upside according to analysts.

Read more »

Vanadium Resources share price person riding rocket indicating share price increase
Speculative

Meet the speculative ASX stock tipped to rise 180%

Bell Potter thinks this share could almost triple in value.

Read more »

People sit in rollercoaster seats with expressions of fear, terror and exhilaration as it goes into a steep downward descent representing the Novonix share price in FY22
AI Stocks

Brainchip share price tumbles 40% in the past year. What's next?

Brainchip shares have had a topsy-turvy year. So, what’s next for this speculative ASX AI technology stock?

Read more »